Both in Pharmaceuticals
Axsome Therapeutics vs Amneal Pharmaceuticals
Over the past year AXSM returned +7.0% and AMRX returned +98.8%; their daily moves had a correlation of 0.22.
AXSM +7.0% AMRX +98.8%Growth of $1, one year, split-adjusted
| Metric | AXSM | AMRX |
|---|---|---|
| Price | $144.43 | $21.51 |
| Market cap | $7.57B | $7.49B |
| Today | +0.68% | +0.75% |
| 1 month | −20.7% | +7.2% |
| 6 months | −30.1% | +67.7% |
| Year to date | −20.9% | +70.7% |
| 1 year | +8.3% | +106.2% |
| Revenue growth (YoY) | +45.5% | +9.9% |
| Gross margin | 93.8% | 42.0% |
| Net margin | −23.5% | 7.2% |
| P/E (TTM) | — | 47.6× |
| Price / sales | 9.7× | 2.4× |
| Net cash | $122.9M | -$2.54B |
| Dividend yield | — | — |
| Volatility (60d) | 37.2% | 37.6% |
| Short % of float | 7.6% | 8.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).